高危非分泌性多发性骨髓瘤,对达拉图巴基化疗反应不佳
Surendra Khanal1, Rameela Rizvi1, Christopher March1
1Internal Medicine, Piedmont Athens Regional, Athens, USA.
Cureus
|March 11, 2025
概括
非分泌性多发性骨髓瘤 (NSMM) 是一个具有挑战性的诊断,由于缺少M蛋白. 这份病例报告详细介绍了一名没有对达拉图穆马布化疗反应的NSMM患者,强调了治疗缺陷.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床医学 临床医学
背景情况:
- 非分泌性多发性骨髓瘤 (NSMM) 是一种罕见的多发性骨髓瘤亚型,其特征是血清或尿液中没有可检测的M蛋白.
- 诊断NSMM是具有挑战性的,通常需要骨髓活检,因为标准的电泳疗法是不够的.
- 目前NSMM的治疗策略是从分泌性多发性髓瘤研究中推断出来的,缺乏具体的基于证据的指导方针.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
